Business Wire

China Yiwu Imported Commodities Fair 2020 to Exhibit Products From 78 Countries and Regions

12.11.2020 09:13:00 EET | Business Wire | Press release

Share

China Yiwu Imported Commodities Fair 2020, as a professional and market-oriented trading platform for imported commodities, will be held on November 13-16, 2020 in Yiwu, an eastern city of China, under the theme “Gather Global Merchants, Share Free Trade Opportunities”.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201111005968/en/

Watch the latest video of Yiwu Imported Commodities Fair here:

https://www.facebook.com/yiwuimportfair/videos/1053171861821233/

https://www.instagram.com/p/CHehVqKHDY0/?igshid=1b48f18hh0rcz

Founded in 2012, the Fair has been continuously making breakthroughs in terms of scale, number of exhibitors and products, and effects. It is regarded as one of the first-choice platforms for overseas brands of daily consumer goods to enter the Chinese market, and is also the first UFI-certified fair for imported consumer goods in China. The exhibiting categories include household articles, maternal & child products, beauty & personal care, crafts & gifts, digital gadgets, food & beverages, liquor & wine, toys, accessories, etc.

The Fair will provide a total of 2020 standard booths with an exhibition area of 50,000 square meters, attracting nearly 1,000 companies. The Fair will present five pavilions: Quality Life Pavilion (Wine & Coffee), Asia Pavilion, Europe Pavilion, America-Oceania-Africa Pavilion, and Quality Life Pavilion (Home Decoration Materials). Exhibits are from 78 countries and regions around the world, including 41 “Belt and Road” countries such as Russia, Poland, Greece, Romania, Ukraine, Turkey, India, Malaysia, Thailand, Iran, Afghanistan, Sri Lanka, and Armenia.

During the Fair, the organizer will also introduce China’s free trade zones, bonded areas and imported commodities markets that are vital to trading business to the exhibitors and buyers. The Fair will also cooperate with domestic and foreign industry societies and form buyer delegations to promote on-site deals for exhibitors. A number of procurement meetings will take place during the Fair to connect overseas brands with domestic distributors. Meanwhile, the Fair will hold new product launch conferences to showcase innovative and quality products for enterprises.

We sincerely invite friends from all over the world to visit China Yiwu Imported Commodities Fair to be held on November 13-16. We will be happy to provide you with the most thoughtful, efficient and warm services, so that everyone can share the harvest and joy of the Fair.

For more:

Official website: http://www.importfair.cn/en

Facebook: https://www.facebook.com/yiwuimportfair/

Instagram: https://www.instagram.com/yiwu_importedfair/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Chim Chen
service@yiwufair.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release

Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release

With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release

Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye